Alpha Tau to Participate in September Investor Conferences

JERUSALEM, September 2, 2026 — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will participate in the following investor conferences in September 2026. Event: Citi’s 2026 Biopharma Back to School Conference Format: 1×1 Meetings Date: […]